Where do Dianthus Therapeutics's ratios come from?

Every ratio is computed from Dianthus Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Liquidity
Current ratio	29.3×+13.3×	13.3×-1.9×	17.3×-1.0×	13.1×-23.3×	16×-26.5×
Quick ratio	29.3×+13.3×	13.3×-1.9×	17.3×-1.0×	13.1×-23.3×	16×-26.5×
Cash ratio	16.4×+15.8×	1.7×+0.4×	2.3×+0.2×	0.7×-30.7×	0.6×-36.2×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Per Share
Book value per share	$25.01+172%	——	$14.46+46.5%	$8.46-19.2%	$9.18-36.8%
Valuation
Market capitalization	$4.44B+662%	$1.77B+174%	$1.57B+67.1%	$583.38M-34.1%	$582.75M-24.3%
Enterprise value	$3.82B+565%	$1.72B+175%	$1.51B+67.3%	$571.48M-0.1%	$574.03M+30.2%
Price / book	3.7×+1.9×	3.6×+1.8×	2.9×+0.1×	1.9×-0.5×	1.8×-0.3×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Dianthus Therapeutics.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Dianthus Therapeutics's ratios come from?: Every ratio is computed from Dianthus Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.